The anti-tumor effect of TCR-Ts expressing TCR-027-004 was further analyzed in vivo in two models using immunodeficient NOD/Shi-scid/IL-2Rγnull mice bearing tumors derived either from the melanoma cell lines Mel624.38 or MelA375_PD-L1. The gene discussed is CD274; the disease is neoplasm.